Stability versus reactivity of '3+1' mixed-ligand technetium-99m complexes in vitro and in vivo

European Journal of Nuclear Medicine

Volumn 25, Issue 7, 1998, Pages 793-796

  Syhre, R ^a   Seifert, S ^a   Spies, H ^a   Gupta, A ^a   Johannsen, B ^a  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

Challenge experiments; Chemical stability; Glutathione; Mixed ligand complexes; Reactivity in vivo and in vitro; Technetium 99m

Indexed keywords

GLUTATHIONE; LIGAND; RADIOPHARMACEUTICAL AGENT; RHENIUM; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CHELATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG METABOLISM; DRUG STABILITY; ERYTHROCYTE; HUMAN; HUMAN CELL; HYDROPHILICITY; METABOLITE; NONHUMAN; PH; RAT;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUTATHIONE; HUMANS; MALE; RATS; RATS, WISTAR; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; SPECTROPHOTOMETRY, ULTRAVIOLET; TECHNETIUM COMPOUNDS;

EID: 0031815279     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050284     Document Type: Article

References (14)

1. Spies H, Pietzsch H-J, Syhre R, Hoffmann S. Lipophilic technetium complexes. VIII. Preparation and animal studies of oxotechnetium(V) complexes with tridentate/monodentate ligand coordination. Isotopenpraxis 1990; 26: 159-162.
2. Spies H, Fietz T, Glaser M, Pietzsch H-J, Johannsen B. The "n+1" concept in the synthesis strategy of novel technetium and rhenium tracers. In: Nicolini M, Bandoli G, Mazzi U, eds. Technetium and rhenium in chemistry and nuclear medicine. Padova: SG Editorialli; 1995; 4: 243-246.
3. Johannsen B, Pietzsch H-J, Scheunemann M, Spies H, Brust P. Oxotechnetium(V) and oxorhenium(V) complexes as potential imaging agents tor the serotonin receptor. J Nucl Med 1995; 36: 27P.
4. Johannsen B, Scheunemann M, Spies H, Brust P, Wober J, Syhre R, Pietzsch H-J. Technetium(V) and rhenium(V) complexes for 5-HT2A serotonin receptor binding: structure-affinity considerations. Nucl Med Biol 1996; 23: 429-438.
5. Mastrostamatis SG, Papadopoulos MS, Pirmettis IC, Paschali E, Varvarigou AD, Stassinopoulou CI, Raptopoulou CP, Terzis A, Chiotellis E. Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain-imaging agents. J Med Chem 1994; 37: 3212-3218.
6. 99mTc complex as a dopamine transporter agent. J Am Chem Soc 1995; 117: 1137-1138.
7. Meegalla S, Plössl K, Kung M-P, Chumpradit S, Stevenson D A, Frederick D, Kung HF. Tc-99m-labelled tropanes as dopamine transporter imaging agents. Bioconjugate Chem 1996; 7: 425-427.
8. Hom RK, Skaddan MB, Katzenellenbogen JA. New structural motifs for oxorhenium(V) complexes whose structures mimic those of estrogen receptor ligands. In: XIIth Intern Symp on Radiopharm Chem (Abstracts), Uppsala, Sweden: 1997; 510-511.
9. Johannsen B, Berger R, Brust P, Pietzsch H-J, Scheunemann M, Scifert S, Spies H, Syhre R. Structural modification of receptor binding technetium-99m complexes in order to improve brain uptake. Eur J Nucl Med 1997; 24: 316-319.
10. Syhre R, Berger R, Brust P, Pietzsch H-J, Seifert S, Scheunemann M, Spies H, Johannsen B. Structural modification of the tridentate ligand of nca "3+1" oxotechnetium(V) mixed-ligand complexes and their effects on the distribution and retention behaviour in rats. Annual Report 1997: FZR-200 (Inst. of Bioinorg. & Radiopharm. Chemistry, Research Center Rossendorf): 58-60.
11. 99mTc complexes. Appl Radiat Isot 1998; 49: 5-11.
12. 99mTc complexes. Annual Report 1997; FZR-200 (Inst. of Bioinorg. & Radiopharm. Chemistry, Research Center Rossendorf): 10-13.
13. Neirinckx RD, Burke JF, Harrison RC, Forster AM, Andersen AR, Lassen N. The retention mechanism of technetium-99m-HM-PAO: intracellular reaction with glutathione. J Cereb Blood Flow Metab 1988; 8: S4-S12.
14. 99mTc complexes containing monothiols of differing nucleophilicity. Eur J Nucl Med 1997; 24: 179.